MétaCan
Menu
← Back to cohort
Record W4406993381 · doi:10.1161/str.56.suppl_1.wmp54

Abstract WMP54: Outcomes of acute ischemic stroke patients in primary stroke centers versus comprehensive stroke centers: a pre-specified analysis of the Alteplase compared to Tenecteplase trial

2025· article· en· W4406993381 on OpenAlexaff
Diego Gutiérrez, Katrina Hannah D. Ignacio, Aleksander Tkach, Herbert Manosalva Alzate, Fouzi Bala, MacKenzie Horn, Houman Khosravani, Jai Shankar, Mohamed Tarek, Gary Hunter, Ayoola Ademola, Dar Dowlatshahi, Richard H. Swartz, Luciana Catanese, Brian Buck, Aravind Ganesh, Tolulope T. Sajobi, Bijoy K. Menon, Mohammed Almekhlafi, Nishita Singh

Bibliographic record

VenueStroke · 2025
Typearticle
Languageen
FieldMedicine
TopicAcute Ischemic Stroke Management
Canadian institutionsSunnybrook Health Science CentreUniversity of OttawaUniversity of AlbertaUniversity of SaskatchewanInterior HealthUniversity of ManitobaMcMaster UniversityUniversity of TorontoUniversity of Calgary
Fundersnot available
KeywordsMedicineTenecteplaseStroke (engine)Ischemic strokeThrombolysisAcute strokeFibrinolytic agentEmergency medicineTissue plasminogen activatorCardiologyPhysical therapyInternal medicineIschemiaMyocardial infarction

Abstract

fetched live from OpenAlex

Background and Objectives: Transportation to comprehensive stroke centers (CSCs) from primary stroke centers (PSCs) is key to achieving fast reperfusion in endovascular treatment (EVT)-eligible patients. We aimed to evaluate outcomes and workflow times of patients treated PSCs vs CSCs and additional key metrics for those transported from PSCs to CSCs for EVT. Methods: We performed a pre-specified analysis of the Alteplase compared to Tenecteplase (AcT) multicenter, randomized, controlled, trial in patients with acute ischemic stroke within 4.5 hours of onset. We compared baseline characteristics, workflow times, and clinical outcomes at 90 days between PSCs and CSCs. Mixed effects regression analyses were performed adjusting for age, sex, National Institute of Health Stroke Scale (NIHSS), location of intracranial occlusion, IVT drug and door-to-needle-time as fixed effects; and study site as a random effect. Results: Of 1,577 patients enrolled in the trial, 99 (6.27%) were treated in PSCs while 1,478 (93.72%) were treated in CSCs. Patients in both groups had similar age (median 72 [64 - 82] vs 74 [63 - 83] years), proportion of females (42.42% vs 48.24%), baseline stroke severity (median NIHSS 9 [6 - 16] vs 10 [6 - 16.5]), presence of large vessel occlusion (24.24% vs 24.70%; p=0.919) and EVT utilization (24.24% vs 32.61%). Patients treated in PSCs had longer onset-to-needle (median, 139 [100 - 190] vs 128 [94 - 185] minutes) and door-to-needle times (median, 56.5 [42 - 70] vs 35 [27 - 47] minutes) compared to those treated at CSCs. For patients transferred from PSCs to CSCs, patients who received tenecteplase had shorter needle-to-puncture times than those who received alteplase (median, 35.5 [21 - 58] vs 52 [18 - 74] minutes, p<0.001). The proportion of patients achieving excellent functional outcome (mRS 0-1) at 90 days was higher at PSCs compared to CSCs (48.48% vs 35.01%, adjusted IRR, 1.42 [CI 95%, 1.04 - 1.95]). Conclusions: Despite less efficient workflows for IVT administration and similarities in baseline characteristics, the proportion of patients receiving initial treatment in PSCs who had excellent functional outcomes was higher compared to CSCs. Among those who received tenecteplase prior to CSC transfer, more efficient time metrics were noted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.054

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.013
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.008
Bibliometrics0.0000.001
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.289
Teacher spread0.269 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueStroke→Same topicAcute Ischemic Stroke Management→French-language works237,207→